| Predicted Trait | |
| Reported Trait | Ovarian cancer | 
| Mapped Trait(s) | ovarian carcinoma (EFO_0001075) | 
| Score Construction | |
| PGS Name | OCPRS_Overall | 
| Development Method | |
| Name | Known susceptibility loci (genome-wide significant SNPs) | 
| Parameters | Most strongly associated variant from each asociated region (p<5x10-8) | 
| Variants | |
| Original Genome Build | GRCh37 | 
| Number of Variants | 17 | 
| Effect Weight Type | NR | 
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000033 | 
| Citation (link to publication) | Kuchenbaecker KB et al. J Natl Cancer Inst (2017) | 
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 100% 13,491 individuals (100%) | 
| PGS Evaluation | European: 100% 2 Sample Sets | 
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | 
|---|---|---|---|
| GWAS Catalog: GCST002748 Europe PMC: 25581431 | 13,491 individuals | European | NR | 
| PGS Performance Metric ID (PPM) | PGS Sample Set ID (PSS) | Performance Source | Trait | PGS Effect Sizes (per SD change) | Classification Metrics | Other Metrics | Covariates Included in the Model | PGS Performance: Other Relevant Information | 
|---|---|---|---|---|---|---|---|---|
| PPM000112 | PSS000072| European Ancestry| 15,252 individuals | PGP000033 | Kuchenbaecker KB et al. J Natl Cancer Inst (2017) | Reported Trait: Ovarian cancer in BRCA1 mutation carriers | HR: 1.28 [1.22, 1.34] | C-index: 0.579 [0.559, 0.6] | — | Country, birth year | — | 
| PPM000113 | PSS000073| European Ancestry| 8,211 individuals | PGP000033 | Kuchenbaecker KB et al. J Natl Cancer Inst (2017) | Reported Trait: Ovarian cancer in BRCA2 mutation carriers | HR: 1.49 [1.34, 1.65] | C-index: 0.628 [0.592, 0.665] | — | Country, birth year | — | 
| PGS Sample Set ID (PSS) | Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information | 
|---|---|---|---|---|---|---|---|---|
| PSS000072 | BRCA1 mutation carriers were followed until the age of ovarian cancer diagnosis, age at risk-reducing salpingo-oophorectomy (RRSO) or age at last observation. Breast cancer diagnosis was not considered as a censoring event in the ovarian cancer analysis | — | [, 
 0.0 % Male samples | — | European | Some analyses accounted for samples part of the larger cohort with Ashkenazi Jewish ancestry | CIMBA | Median censoring age (cases) = 50 | 
| PSS000073 | BRCA2 mutation carriers were followed until the age of ovarian cancer diagnosis, age at risk-reducing salpingo-oophorectomy (RRSO) or age at last observation. Breast cancer diagnosis was not considered as a censoring event in the ovarian cancer analysis | — | [, 
 0.0 % Male samples | — | European | Some analyses accounted for samples part of the larger cohort with Ashkenazi Jewish ancestry | CIMBA | Median censoring age (cases) = 57 |